1
|
Fox JJ, Schöder H and Larson SM: Molecular
imaging of prostate cancer. Curr Opin Urol. 22:320–327. 2012.
View Article : Google Scholar
|
2
|
Ouyang DY, Xu LH, He XH, et al: Autophagy
is differentially induced in prostate cancer LNCaP, DU145 and PC-3
cells via distinct splicing profiles of ATG5. Autophagy. 9:20–32.
2013. View Article : Google Scholar
|
3
|
Hao Y, Zhao Y, Zhao X, et al: Improvement
of prostate cancer detection by integrating the PSA test with miRNA
expression profiling. Cancer Invest. 29:318–324. 2011. View Article : Google Scholar : PubMed/NCBI
|
4
|
Damber JE and Aus G: Prostate cancer.
Lancet. 371:1710–1721. 2008. View Article : Google Scholar : PubMed/NCBI
|
5
|
Eastham JA, May RA, Whatley T, Crow A,
Venable DD and Sartor O: Clinical characteristics and biopsy
specimen features in African-American and white men without
prostate cancer. J Natl Cancer Instit. 90:756–760. 1998. View Article : Google Scholar : PubMed/NCBI
|
6
|
Mononen N and Schleutker J: Polymorphisms
in genes involved in androgen pathways as risk factors for prostate
cancer. J Urol. 181:1541–1549. 2009. View Article : Google Scholar : PubMed/NCBI
|
7
|
Berasain C, Castillo J, Perugorria MJ,
Latasa MU, Prieto J and Avila MA: Inflammation and liver cancer:
new molecular links. Ann NY Acad Sci. 1155:206–221. 2009.
View Article : Google Scholar : PubMed/NCBI
|
8
|
Coyle YM: Lifestyle, genes, and cancer.
Methods Mol Biol. 472:25–56. 2009. View Article : Google Scholar : PubMed/NCBI
|
9
|
Wu H, Haag D, Muley T, et al:
Tumor-microenvironment interactions studied by zonal
transcriptional profiling of squamous cell lung carcinoma. Genes
Chromosomes Cancer. 52:250–264. 2013. View Article : Google Scholar
|
10
|
Liotta LA and Kohn EC: The
microenvironment of the tumour-host interface. Nature. 411:375–379.
2001. View
Article : Google Scholar : PubMed/NCBI
|
11
|
López-Otín C and Matrisian LM: Emerging
roles of proteases in tumour suppression. Nat Rev Cancer.
7:800–808. 2007.PubMed/NCBI
|
12
|
Hua H, Li M, Luo T, Yin Y and Jiang Y:
Matrix metalloproteinases in tumorigenesis: an evolving paradigm.
Cell Mol Life Sci. 68:3853–3868. 2011. View Article : Google Scholar : PubMed/NCBI
|
13
|
Orlichenko LS and Radisky DC: Matrix
metalloproteinases stimulate epithelial-mesenchymal transition
during tumor development. Clin Exp Metastasis. 25:593–600. 2008.
View Article : Google Scholar
|
14
|
Mochizuki S and Okada Y: ADAMs in cancer
cell proliferation and progression. Cancer Sci. 98:621–628. 2007.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Rocks N, Paulissen G, El Hour M, et al:
Emerging roles of ADAM and ADAMTS metalloproteinases in cancer.
Biochimie. 90:369–379. 2008. View Article : Google Scholar : PubMed/NCBI
|
16
|
Edwards DR, Handsley MM and Pennington CJ:
The ADAM metalloproteinases. Mol Aspects Med. 29:258–289. 2008.
View Article : Google Scholar
|
17
|
Seals DF and Courtneidge SA: The ADAMs
family of metalloproteases: multidomain proteins with multiple
functions. Genes Dev. 17:7–30. 2003. View Article : Google Scholar
|
18
|
Grabowska MM, Sandhu B and Day ML: EGF
promotes the shedding of soluble E-cadherin in an ADAM10-dependent
manner in prostate epithelial cells. Cell Signal. 24:532–538. 2012.
View Article : Google Scholar : PubMed/NCBI
|
19
|
Maretzky T, Scholz F, Köten B, Proksch E,
Saftig P and Reiss K: ADAM10-mediated E-cadherin release is
regulated by proinflammatory cytokines and modulates keratinocyte
cohesion in eczematous dermatitis. J Invest Dermatol.
128:1737–1746. 2008. View Article : Google Scholar
|
20
|
Schirrmeister W, Gnad T, Wex T, et al:
Ectodomain shedding of E-cadherin and c-Met is induced by
Helicobacter pylori infection. Exp Cell Res. 315:3500–3508.
2009. View Article : Google Scholar : PubMed/NCBI
|
21
|
Arima T, Enokida H, Kubo H, et al: Nuclear
translocation of ADAM-10 contributes to the pathogenesis and
progression of human prostate cancer. Cancer Science. 98:1720–1726.
2007. View Article : Google Scholar
|
22
|
Liu WH and Chang LS: Piceatannol induces
Fas and FasL up-regulation in human leukemia U937 cells via
Ca2+/p38alpha MAPK-mediated activation of c-Jun and
ATF-2 pathways. Int J Biochem Cell Biol. 42:1498–1506. 2010.
View Article : Google Scholar : PubMed/NCBI
|
23
|
McCulloch DR, Akl P, Samaratunga H,
Herington AC and Odorico DM: Expression of the disintegrin
metalloprotease, ADAM-10, in prostate cancer and its regulation by
dihydrotestosterone, insulin-like growth factor I, and epidermal
growth factor in the prostate cancer cell model LNCaP. Clin Cancer
Res. 10:314–323. 2004. View Article : Google Scholar
|
24
|
Blobel CP: ADAMs: key components in EGFR
signalling and development. Nat Rev Mol Cell Biol. 6:32–43. 2005.
View Article : Google Scholar : PubMed/NCBI
|
25
|
Lamour NF, Wijesinghe DS, Mietla JA, Ward
KE, Stahelin RV and Chalfant CE: Ceramide kinase regulates the
production of tumor necrosis factor alpha (TNFalpha) via inhibition
of TNFα-converting enzyme. J Biol Chem. 286:42808–42817. 2011.
|
26
|
Szlosarek PW and Balkwill FR: Tumour
necrosis factor alpha: a potential target for the therapy of solid
tumours. Lancet Oncol. 4:565–573. 2003. View Article : Google Scholar : PubMed/NCBI
|
27
|
Cuadrado A and Nebreda AR: Mechanisms and
functions of p38 MAPK signalling. Biochem J. 429:403–417. 2010.
View Article : Google Scholar : PubMed/NCBI
|
28
|
Cargnello M and Roux PP: Activation and
function of the MAPKs and their substrates, the MAPK-activated
protein kinases. Microbiol Mol Biol Rev. 75:50–83. 2011. View Article : Google Scholar : PubMed/NCBI
|
29
|
Chung KF: p38 mitogen-activated protein
kinase pathways in asthma and COPD. Chest. 139:1470–1479. 2011.
View Article : Google Scholar : PubMed/NCBI
|
30
|
Karin M: Nuclear factor-kappaB in cancer
development and progression. Nature. 441:431–436. 2006. View Article : Google Scholar : PubMed/NCBI
|
31
|
Bhoj VG and Chen ZJ: Ubiquitylation in
innate and adaptive immunity. Nature. 458:430–437. 2009. View Article : Google Scholar : PubMed/NCBI
|
32
|
Karin M and Greten FR: NF-kappaB: linking
inflammation and immunity to cancer development and progression.
Nat Rev Immunol. 5:749–759. 2005. View
Article : Google Scholar : PubMed/NCBI
|
33
|
Strasser A, Jost PJ and Nagata S: The many
roles of FAS receptor signaling in the immune system. Immunity.
30:180–192. 2009. View Article : Google Scholar : PubMed/NCBI
|
34
|
Krammer PH: CD95’s deadly mission in the
immune system. Nature. 407:789–795. 2000.
|
35
|
Villa-Morales M and Fernández-Piqueras J:
Targeting the Fas/FasL signaling pathway in cancer therapy. Expert
Opin Ther Targets. 16:85–101. 2012. View Article : Google Scholar : PubMed/NCBI
|
36
|
Liu WH and Chang LS: Fas/FasL-dependent
and -independent activation of caspase-8 in doxorubicin-treated
human breast cancer MCF-7 cells: ADAM10 down-regulation activates
Fas/FasL signaling pathway. Int J Biochem Cell Biol. 43:1708–1719.
2011. View Article : Google Scholar
|